Novel targets in the treatment of advanced melanoma: new first-line treatment options. - Wikidata - wikimedia - TriplyDB

Novel targets in the treatment of advanced melanoma: new first-line treatment options.

Novel targets in the treatment of advanced melanoma: new first-line treatment options.

http://www.wikidata.org/entity/Q38095228

about

Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatment Antibody therapies for melanoma: new and emerging opportunities to activate immunity (Review).Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma metastasis Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells.Getting personal: Head and neck cancer management in the era of genomic medicine.Infectious Colitis Associated With Ipilimumab Therapy.Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.Emerging trends in the epidemiology of melanoma.Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticles.Bilateral Facial Palsy following Ipilimumab Infusion for Melanoma.Dabrafenib: first global approval.

P2860

Q26776032-5598CD6C-FE74-4B56-88C5-0248AB6EA341 Q34000700-0B0E08FA-B1DC-4C9C-ACC6-2A0E0A4DD443 Q35605710-E15AB328-B610-44C8-9E6C-EFF8FB013093 Q35835269-6AC066BE-6C4E-473D-8D67-925DF5401ED6 Q36303715-537D4596-7908-41DF-9715-4689E3DE2750 Q37311734-587473F1-1225-4D9B-92BD-1F27FD82E21E Q37418121-D089C5FE-2EE2-4670-AFAE-ED15B5E34180 Q38118359-EB47846C-09F7-4185-AB24-63A097ED074F Q41962637-E44A790E-4C27-4F79-AD4A-600A45D55911 Q44381731-178A05A2-D58E-438A-88E7-0EA92B6CD1B2 Q46734875-A9BE4DB8-D425-4D36-92FD-BA4179EAB500

P2860

Novel targets in the treatment of advanced melanoma: new first-line treatment options.

http://www.wikidata.org/entity/Q38095228

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel targets in the treatment of advanced melanoma: new first-line treatment options.

@en

type

label

Novel targets in the treatment of advanced melanoma: new first-line treatment options.

@en

prefLabel

Novel targets in the treatment of advanced melanoma: new first-line treatment options.

@en

P1433

Q38095228-5331D830-6EA6-4389-89F8-CC3F8342EE67

P1476

Q38095228-F0233A0F-605B-4812-AC7B-9F7141BEBF86

P2093

Q38095228-7FBC1851-8F5C-4723-B91C-E82B48381F89

Q38095228-B4DE1255-C099-4F92-B8BA-0921D19B91DB

P2860

Q38095228-12231777-6A92-46A8-B4A6-F616497C6554

Q38095228-167DC582-ECF4-4418-B9C1-0062240B2752

Q38095228-36658715-96FC-4B2A-8FB8-50B8C560685E

Q38095228-442C1FC1-7B09-49E2-8899-349B1E70ECC7

Q38095228-46DE4F7B-A055-4DAE-A391-CD01527F3B60

Q38095228-49DF42B8-ADD9-4B29-818C-5EBD9EDB8C03

Q38095228-508ACD89-7971-480C-AAFF-BD2DBD98BF6F

Q38095228-5FE4F02A-67EE-42B9-BC93-5D301B97C7B8

Q38095228-633083A9-CDED-448A-9102-9EEC6C21E902

Q38095228-6353CF1B-F271-40BA-AD1B-AA4C63EDD0C8

P304

Q38095228-00377F57-41E0-435F-A870-CECAE1E65AAB

P31

Q38095228-8DDFC813-5EBF-42EB-AAAA-B29698021253

P356

Q38095228-F9FE8D27-930E-49F5-9ECA-E2E22ED855D6

P407

Q38095228-CA434660-6B06-4B5A-900B-CCF43A07E933

P433

Q38095228-6CC11613-55AE-4D77-9BE2-9A419D85F729

P478

Q38095228-8089BD01-8645-4FC9-AF4C-92ADA2EEDEB1

P577

Q38095228-DA3FC0B5-F277-44FE-8F9B-55EE72C269D6

P698

Q38095228-BF887134-72B0-4870-9242-AAE663D14B64

P356

P1433

Annals of Pharmacotherapy

P1476

Novel targets in the treatment of advanced melanoma: new first-line treatment options.

@en

P2093

Kathryn A Culos

http://www.w3.org/2001/XMLSchema#string

Sandra Cuellar

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Mutations of the BRAF gene in human cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

P304

519-526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1R614

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23548648

http://www.w3.org/2001/XMLSchema#string